Enveric Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISORSHARES INVESTMENTS LLC | 11/14/2024 | 367,047 | $173,980 | 15.77% | 4.22% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 217,893 | $103,280 | 387.90% | 2.50% |
| TWO SIGMA SECURITIES, LLC | 11/14/2024 | 30,632 | $14,520 | 101.00% | 0.35% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 23,117 | $11,000 | 67.61% | 0.27% |
| VANGUARD GROUP INC | 11/13/2024 | 18,198 | $8,626 | 0.00% | 0.21% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 17,372 | $8,234 | 51.65% | 0.20% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 13,385 | $6,344 | 100.00% | 0.15% |
| CITADEL ADVISORS LLC | 11/14/2024 | 12,753 | $6,045 | 100.00% | 0.15% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 9,010 | $4,271 | 100.00% | 0.10% |
| UBS GROUP AG | 11/14/2024 | 731 | $346 | -98.32% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 575 | $271 | -6.50% | 0.01% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 273 | $129 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 173 | $82 | 5.49% | 0.00% |
| NATIONAL BANK OF CANADA /FI/ | 11/15/2024 | 71 | $34 | 1.43% | 0.00% |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 11/08/2024 | 50 | $23 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 16 | $8 | 0.00% | 0.00% |
| FMR LLC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| MATHER GROUP, LLC. | 10/07/2024 | 0 | $0 | -100.00% | 0.00% |
| ORG PARTNERS LLC | 10/11/2024 | 0 | $0 | -100.00% | 0.00% |
Enveric Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Enveric Biosciences, Inc.. The most heavily invested institutionals were:
AdvisorShares Investments LLC: 367,047
GEODE CAPITAL MANAGEMENT, LLC: 217,893
TWO SIGMA SECURITIES, LLC: 30,632
Virtu Financial LLC: 23,117
VANGUARD GROUP INC: 18,198
Tower Research Capital LLC (TRC): 17,372
8.17% of Enveric Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 740,874 shares in the last 24 months. This purchase volume represents approximately $229,671 in transactions.